CME.NASDAQCme Group INC

8-K: CME Group Reports Record Annual Revenue and Earnings for 2024

Sentiment:

Earnings Report


CME Group announces record-breaking annual financial results for 2024, driven by volume growth across all asset classes.

Better than expectedThe company achieved record annual revenue, adjusted operating income, adjusted net income, and adjusted earnings per share.The company's Q4 performance was strong, with a 6% increase in revenue, adjusted net income, and adjusted earnings per share.

Summary

  • CME Group reported record annual revenue of $6.1 billion for 2024, a 10% increase from the previous year.
  • The company's operating income for the full year was $3.9 billion, with a net income of $3.5 billion.
  • Diluted earnings per common share reached $9.67, and on an adjusted basis, net income was $3.7 billion with diluted earnings per share of $10.26.
  • For the fourth quarter of 2024, CME Group reported revenue of $1.5 billion and operating income of $947 million.
  • Net income for Q4 was $875 million, with diluted earnings per share at $2.40, or $2.52 on an adjusted basis.
  • Average daily volume (ADV) for the fourth quarter was 25.5 million contracts, consistent with the same period in 2023, with non-U.S. ADV up 5% to 7.6 million contracts.
  • Clearing and transaction fees revenue for Q4 totaled $1.2 billion, with an average rate per contract of $0.701.
  • Market data revenue for the fourth quarter was $182 million.
  • As of December 31, 2024, the company held approximately $3.1 billion in cash and $3.4 billion in debt.
  • CME Group declared dividends of $3.8 billion during 2024, including a $2.1 billion variable dividend.
  • A first-quarter dividend of $1.25 per share was declared on February 6, 2025, representing a 9% increase.

Sentiment

Score: 9

Explanation: The document presents a highly positive outlook with record financial results and increased dividends, indicating strong performance and shareholder value.

Positives

  • Record annual revenue, adjusted operating income, adjusted net income, and adjusted earnings per share were achieved in 2024.
  • Volume growth was seen across every asset class, including interest rates, agricultural, foreign exchange, and metals markets.
  • The company has returned over $28 billion to shareholders in the form of dividends since 2012.
  • The first-quarter dividend was increased by 9% to $1.25 per share.

Risks

  • The company acknowledges continuing economic and geopolitical uncertainty.
  • The document lists a number of factors that might affect performance, including increasing competition, technological developments, regulatory changes, and economic conditions.
  • The company's performance is subject to volatility in commodity, equity, and fixed income prices.

Future Outlook

Amid continuing economic and geopolitical uncertainty, CME Group will continue to serve its global clients by providing the products, services, and efficiencies they need to manage risk and pursue opportunities to meet their business needs.

Management Comments

  • In 2024, CME Group had its best year ever, generating record annual average daily volume, revenue, adjusted operating income, adjusted net income and adjusted earnings per share, according to Terry Duffy, CME Group Chairman and Chief Executive Officer.
  • With volume growth across every asset class, we hit new records in interest rates, including U.S. Treasury and SOFR complexes, as well as in agricultural, foreign exchange and metals markets, according to Terry Duffy, CME Group Chairman and Chief Executive Officer.
  • Our Q4 performance also was very strong, delivering a 6% increase in revenue, adjusted net income and adjusted earnings per share, according to Terry Duffy, CME Group Chairman and Chief Executive Officer.

Industry Context

CME Group's strong performance reflects the continued demand for risk management tools in a volatile global market. The company's diverse product offerings across multiple asset classes position it well to capitalize on various market trends and economic conditions.

Comparison to Industry Standards

  • CME Group's record revenue and earnings place it among the top performers in the exchange and clearing house industry.
  • Competitors such as Intercontinental Exchange (ICE) and Nasdaq also benefit from market volatility and increased trading activity.
  • CME Group's ADV of 25.5 million contracts in Q4 2024 demonstrates its leading position in the derivatives marketplace.
  • The company's focus on innovation and global expansion aligns with industry trends.

Stakeholder Impact

  • Shareholders will benefit from increased dividends and strong earnings per share.
  • Customers will continue to have access to a wide range of risk management tools and services.
  • Employees may experience increased job security and potential for career advancement due to the company's strong performance.

Next Steps

  • CME Group will hold a Q&A conference call to discuss fourth-quarter 2024 results at 8:30 a.m. Eastern Time today.

Key Dates

DateDescription
Early 2012Implementation of the variable dividend policy.
December 31, 2023Date of the Annual Report on Form 10-K filing with the SEC.
February 28, 2024Filing date of the Annual Report on Form 10-K with the SEC.
December 31, 2024End of the fourth quarter and full year 2024.
February 6, 2025Declaration date of the first-quarter dividend of $1.25 per share.
February 12, 2025Date of the earnings report release and Q&A conference call.

Keywords

revenue, earnings, dividends, financial results, CME Group, ADV, volume, derivatives, futures, options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.